Abstract
Declining recruitment rates in inflammatory bowel disease (IBD) trials have resulted in calls to modify the conduct of trials in IBD in order to make them more efficient and patient centred. Here, we propose a number of potential modifications.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
COVID-19
-
Clinical Trials as Topic / methods
-
Clinical Trials as Topic / organization & administration*
-
Humans
-
Inflammatory Bowel Diseases*
-
Informed Consent
-
Patient Acceptance of Health Care
-
Patient Outcome Assessment
-
Patient Reported Outcome Measures
-
Patient Satisfaction
-
Patient Selection
-
Patient-Centered Care*
-
SARS-CoV-2
-
Self-Testing
-
Telemedicine
-
Therapeutic Equipoise